SlideShare uma empresa Scribd logo
1 de 20
Edward Lynam, MD
          Medical Director
Quest Counseling, Reno, NV
Remembering History
 “Those who cannot remember the past are doomed to
  repeat it.”
 George Santayana
Commercialization of Opiates 1
 British East India Company
 Tea from China
 Boston Tea Party!
 Silver to China
 Silver shortages
 Opium from Bengal/India to China
 Qing Dynasty
 Opium War(s)
 Silver and Tea from China, Opium to China
China
 By 1940: 40 million opium addicts, 10% of population
 A century of corruption, decline, and defeat
 Mao and Communists: solved addiction problem
Commercialization of Opiates 2
 Purdue Pharma, 1990’s
 Oxycontin: sustained release oxycodone
 Marketing drove it from $48 million in 1996 to $1
    billion in 2001
   $200 million in marketing in 2001 alone
   Free 7 to 30 day supplies
   Bonuses to sales staff more than base salary
   5000 health professionals given all expense paid stays
    at fancy resorts to become speakers
Medical Use of Oral Opiates
 Dysentery and Diarrhea (historical)
 Cough Suppression (rare)
 Pain Management
    Acute
       Pre-op
       Op
       Post-op
   Chronic
       Cancer, end of life: palliative
       Non-cancer
Effects of Opiates
 CNS and PNS opiate receptors (therapeutic):
    Decreased pain perception: analgesia
    Decreased reaction to pain: psychological
    Increased tolerance to pain: more functional activity
    Mild to severe neurocognitive impairment
    Nausea and/or Constipation
    Itching and miosis
    Immune/Reproductive hormone changes
    Accidents and delayed return to employment
Effects of Opiates in Addiction
 Above therapeutic dosage
    Euphoria: false sense of exaggerated well being
    Accelerated development of tolerance
    Respiratory depression leading to hypoxic death
        Cuts the normal response to carbon dioxide
        Lungs can fill with fluid
        Tolerance to this effect not predictable at high doses
        Half of deaths had used another respiratory depressant
Misuse of Prescription Opiates
30 to 40% of
 prescribed doses are
 not used properly
Engaging Prescribers
  Federal Efforts: starting 2011
   Office of National Drug Control Policy
    (ONDCP)
   Food and Drug Administration (FDA)

   Drug Enforcement Administration
    (DEA)
Strategy
 Expand awareness and education to physicians,
  researchers, and the public
 Expand efforts to monitor the prescribing of these
  drugs, including calling upon every state to set up
  a program (43 so far)
 Make it easier for consumers to dispose of drugs
 Shut down “pill mills” and reduce doctor shopping
Educating Prescribers
 Training: substance abuse in general curriculum
 DEA licensure: requiring specific educational content
 Manufacturers: requiring “re”-educational funding
Opioid Risk Evaluation and Mitigation Strategy (REMS)


 Physicians for Responsible Opioid Prescribing (PROP)
 Best Practices for Emergency Medicine
Washington State
 Agency Medical Directors Group
    Published guidelines
    Opiate dosing calculator (web and app)
    Free patient assessment tools
    Free 4 hour CME activity
    Searchable Directory of Pain Management Specialists
    Other resources
What do prescribers need to do?
 Establish a clear upper limit on dosing
 Written care agreements
    No early refills or replacement of lost or stolen
    Refills only on clinic visits
    Random urine screening
 Red flags: end access
 State monitoring system
 Engage family in safety education
Conclusion
 Historically Opiate Addiction is linked to
    commercialization
   Prescription Opiates have legitimate medical role
   A large percentage end up being misused or abused
   Unintentional deaths have skyrocketed
   Public education is important
   Prescribers need greater education
   States can help with monitoring, disposal programs,
    shutting down pill mills, and doctor shopping

Mais conteúdo relacionado

Mais procurados

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Peter VanPelt
Peter VanPeltPeter VanPelt
Peter VanPeltOPUNITE
 
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...University of Michigan Injury Center
 
Preventing Prescription Opioid Overdoses: Changing Patients' Risky Opioid Us...
Preventing Prescription Opioid Overdoses: Changing Patients'  Risky Opioid Us...Preventing Prescription Opioid Overdoses: Changing Patients'  Risky Opioid Us...
Preventing Prescription Opioid Overdoses: Changing Patients' Risky Opioid Us...University of Michigan Injury Center
 
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...University of Michigan Injury Center
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisOPUNITE
 
Presentation
PresentationPresentation
Presentationayonemoto
 
SMOKING CESSATION _ CODP 8
SMOKING CESSATION _ CODP 8SMOKING CESSATION _ CODP 8
SMOKING CESSATION _ CODP 8SoM
 
Modafinil smackdown
Modafinil smackdownModafinil smackdown
Modafinil smackdownJason webb
 
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPHImproving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPHUniversity of Michigan Injury Center
 
Rx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonRx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonOPUNITE
 
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...University of Michigan Injury Center
 
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?Canadian Cancer Survivor Network
 
M christensen pain+management
M christensen pain+managementM christensen pain+management
M christensen pain+managementLaurie Crane
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroOPUNITE
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderOPUNITE
 

Mais procurados (20)

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Peter VanPelt
Peter VanPeltPeter VanPelt
Peter VanPelt
 
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
 
Preventing Prescription Opioid Overdoses: Changing Patients' Risky Opioid Us...
Preventing Prescription Opioid Overdoses: Changing Patients'  Risky Opioid Us...Preventing Prescription Opioid Overdoses: Changing Patients'  Risky Opioid Us...
Preventing Prescription Opioid Overdoses: Changing Patients' Risky Opioid Us...
 
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harris
 
Presentation
PresentationPresentation
Presentation
 
Udt pdmp cme 2015
Udt pdmp cme 2015Udt pdmp cme 2015
Udt pdmp cme 2015
 
SMOKING CESSATION _ CODP 8
SMOKING CESSATION _ CODP 8SMOKING CESSATION _ CODP 8
SMOKING CESSATION _ CODP 8
 
Modafinil smackdown
Modafinil smackdownModafinil smackdown
Modafinil smackdown
 
Group 5 presentation on otc drugs
Group 5 presentation on otc drugsGroup 5 presentation on otc drugs
Group 5 presentation on otc drugs
 
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPHImproving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
 
Rx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonRx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okeson
 
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...
 
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?
 
M christensen pain+management
M christensen pain+managementM christensen pain+management
M christensen pain+management
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
 
Chronic Opioid Therapy
Chronic Opioid TherapyChronic Opioid Therapy
Chronic Opioid Therapy
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
 

Semelhante a Lynam presentation

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
The Opioid Crisis – 
Big Pharma Marketing and the dangers of extrapolation.
The Opioid Crisis – 
Big Pharma Marketing and the dangers of extrapolation.The Opioid Crisis – 
Big Pharma Marketing and the dangers of extrapolation.
The Opioid Crisis – 
Big Pharma Marketing and the dangers of extrapolation.Aaron Garner
 
Pain & Addiction 2009
Pain & Addiction 2009Pain & Addiction 2009
Pain & Addiction 2009Stacy Seikel
 
The Highs And Lows Of Opiate Management
The Highs And Lows Of Opiate ManagementThe Highs And Lows Of Opiate Management
The Highs And Lows Of Opiate Managementguest2e3167
 
prescription drug abuse
prescription drug abuseprescription drug abuse
prescription drug abusekelseyp6
 
Contemporary Social Issue Presentation on Prescription Abuse
Contemporary Social Issue Presentation on Prescription Abuse Contemporary Social Issue Presentation on Prescription Abuse
Contemporary Social Issue Presentation on Prescription Abuse Kelseynarin
 
Teresa alves - selling sickness 2010
Teresa alves -  selling sickness 2010Teresa alves -  selling sickness 2010
Teresa alves - selling sickness 2010Gezonde scepsis
 
Drug use mis use and abuse
Drug use mis use and abuse Drug use mis use and abuse
Drug use mis use and abuse Zainab&Sons
 
final duplication and misuse ppt
final duplication and misuse pptfinal duplication and misuse ppt
final duplication and misuse pptshahin ghori
 
Pain points - Overcoming the Opioid Crisis
Pain points - Overcoming the Opioid CrisisPain points - Overcoming the Opioid Crisis
Pain points - Overcoming the Opioid CrisisCompleteRx
 
Topical pain medications another approach to pain, wound and scar management...
Topical pain medications  another approach to pain, wound and scar management...Topical pain medications  another approach to pain, wound and scar management...
Topical pain medications another approach to pain, wound and scar management...Valuecare pharmacy
 
Introduction to pharmacovigilance
Introduction to pharmacovigilanceIntroduction to pharmacovigilance
Introduction to pharmacovigilanceNahla Amin
 
Non-Dependence Producing Drugs in the Treatment of Addictions
Non-Dependence Producing Drugs in the Treatment of AddictionsNon-Dependence Producing Drugs in the Treatment of Addictions
Non-Dependence Producing Drugs in the Treatment of AddictionsBrendan Quinn
 
Phil Walls
Phil WallsPhil Walls
Phil WallsOPUNITE
 
Rx15 pharma wed_430_1_green_2yamada-dole
Rx15 pharma wed_430_1_green_2yamada-doleRx15 pharma wed_430_1_green_2yamada-dole
Rx15 pharma wed_430_1_green_2yamada-doleOPUNITE
 
Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingMark Scott
 

Semelhante a Lynam presentation (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
The Opioid Crisis – 
Big Pharma Marketing and the dangers of extrapolation.
The Opioid Crisis – 
Big Pharma Marketing and the dangers of extrapolation.The Opioid Crisis – 
Big Pharma Marketing and the dangers of extrapolation.
The Opioid Crisis – 
Big Pharma Marketing and the dangers of extrapolation.
 
Pain & Addiction 2009
Pain & Addiction 2009Pain & Addiction 2009
Pain & Addiction 2009
 
The Highs And Lows Of Opiate Management
The Highs And Lows Of Opiate ManagementThe Highs And Lows Of Opiate Management
The Highs And Lows Of Opiate Management
 
prescription drug abuse
prescription drug abuseprescription drug abuse
prescription drug abuse
 
Contemporary Social Issue Presentation on Prescription Abuse
Contemporary Social Issue Presentation on Prescription Abuse Contemporary Social Issue Presentation on Prescription Abuse
Contemporary Social Issue Presentation on Prescription Abuse
 
Twillman preventing rx abuse
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
 
Teresa alves - selling sickness 2010
Teresa alves -  selling sickness 2010Teresa alves -  selling sickness 2010
Teresa alves - selling sickness 2010
 
Drug use mis use and abuse
Drug use mis use and abuse Drug use mis use and abuse
Drug use mis use and abuse
 
Rise in Opioid Overdoses – Prevention Strategies
Rise in Opioid Overdoses – Prevention StrategiesRise in Opioid Overdoses – Prevention Strategies
Rise in Opioid Overdoses – Prevention Strategies
 
final duplication and misuse ppt
final duplication and misuse pptfinal duplication and misuse ppt
final duplication and misuse ppt
 
Pain points - Overcoming the Opioid Crisis
Pain points - Overcoming the Opioid CrisisPain points - Overcoming the Opioid Crisis
Pain points - Overcoming the Opioid Crisis
 
Bagful Of Pills
Bagful Of PillsBagful Of Pills
Bagful Of Pills
 
Topical pain medications another approach to pain, wound and scar management...
Topical pain medications  another approach to pain, wound and scar management...Topical pain medications  another approach to pain, wound and scar management...
Topical pain medications another approach to pain, wound and scar management...
 
Introduction to pharmacovigilance
Introduction to pharmacovigilanceIntroduction to pharmacovigilance
Introduction to pharmacovigilance
 
Non-Dependence Producing Drugs in the Treatment of Addictions
Non-Dependence Producing Drugs in the Treatment of AddictionsNon-Dependence Producing Drugs in the Treatment of Addictions
Non-Dependence Producing Drugs in the Treatment of Addictions
 
Phil Walls
Phil WallsPhil Walls
Phil Walls
 
Rx15 pharma wed_430_1_green_2yamada-dole
Rx15 pharma wed_430_1_green_2yamada-doleRx15 pharma wed_430_1_green_2yamada-dole
Rx15 pharma wed_430_1_green_2yamada-dole
 
Prescribing Opioids in the ED
Prescribing Opioids in the EDPrescribing Opioids in the ED
Prescribing Opioids in the ED
 
Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care Setting
 

Mais de dcuniversegirl (20)

Sam dc-1-2
Sam dc-1-2Sam dc-1-2
Sam dc-1-2
 
Mead presentation
Mead presentationMead presentation
Mead presentation
 
Voth presentation
Voth presentationVoth presentation
Voth presentation
 
Electronic (e) cigarettes ntpc march 2014
Electronic (e) cigarettes ntpc march 2014Electronic (e) cigarettes ntpc march 2014
Electronic (e) cigarettes ntpc march 2014
 
Trends 2
Trends 2Trends 2
Trends 2
 
Rap pres susan pintar
Rap pres susan pintarRap pres susan pintar
Rap pres susan pintar
 
Rap pres steve wiener
Rap pres steve wienerRap pres steve wiener
Rap pres steve wiener
 
Rap pres jon hager
Rap pres jon hagerRap pres jon hager
Rap pres jon hager
 
Pintar
PintarPintar
Pintar
 
Ac ask powerpoint
Ac ask powerpointAc ask powerpoint
Ac ask powerpoint
 
Pohl presentation
Pohl presentationPohl presentation
Pohl presentation
 
Sabet presentation
Sabet presentationSabet presentation
Sabet presentation
 
Rusche 2 presentation
Rusche 2 presentationRusche 2 presentation
Rusche 2 presentation
 
Pinson presentation
Pinson presentationPinson presentation
Pinson presentation
 
Kallal presentation
Kallal presentationKallal presentation
Kallal presentation
 
Jones presentation
Jones presentationJones presentation
Jones presentation
 
Dutchover presentation
Dutchover presentationDutchover presentation
Dutchover presentation
 
Bath salts
Bath saltsBath salts
Bath salts
 
Rx otc
Rx otcRx otc
Rx otc
 
Underage drinking
Underage drinkingUnderage drinking
Underage drinking
 

Lynam presentation

  • 1. Edward Lynam, MD Medical Director Quest Counseling, Reno, NV
  • 2. Remembering History  “Those who cannot remember the past are doomed to repeat it.”  George Santayana
  • 3.
  • 4. Commercialization of Opiates 1  British East India Company  Tea from China  Boston Tea Party!  Silver to China  Silver shortages  Opium from Bengal/India to China  Qing Dynasty  Opium War(s)  Silver and Tea from China, Opium to China
  • 5. China  By 1940: 40 million opium addicts, 10% of population  A century of corruption, decline, and defeat  Mao and Communists: solved addiction problem
  • 6. Commercialization of Opiates 2  Purdue Pharma, 1990’s  Oxycontin: sustained release oxycodone  Marketing drove it from $48 million in 1996 to $1 billion in 2001  $200 million in marketing in 2001 alone  Free 7 to 30 day supplies  Bonuses to sales staff more than base salary  5000 health professionals given all expense paid stays at fancy resorts to become speakers
  • 7. Medical Use of Oral Opiates  Dysentery and Diarrhea (historical)  Cough Suppression (rare)  Pain Management  Acute  Pre-op  Op  Post-op  Chronic  Cancer, end of life: palliative  Non-cancer
  • 8. Effects of Opiates  CNS and PNS opiate receptors (therapeutic):  Decreased pain perception: analgesia  Decreased reaction to pain: psychological  Increased tolerance to pain: more functional activity  Mild to severe neurocognitive impairment  Nausea and/or Constipation  Itching and miosis  Immune/Reproductive hormone changes  Accidents and delayed return to employment
  • 9. Effects of Opiates in Addiction  Above therapeutic dosage  Euphoria: false sense of exaggerated well being  Accelerated development of tolerance  Respiratory depression leading to hypoxic death  Cuts the normal response to carbon dioxide  Lungs can fill with fluid  Tolerance to this effect not predictable at high doses  Half of deaths had used another respiratory depressant
  • 10.
  • 11.
  • 12.
  • 13.
  • 14. Misuse of Prescription Opiates 30 to 40% of prescribed doses are not used properly
  • 15. Engaging Prescribers  Federal Efforts: starting 2011  Office of National Drug Control Policy (ONDCP)  Food and Drug Administration (FDA)  Drug Enforcement Administration (DEA)
  • 16. Strategy  Expand awareness and education to physicians, researchers, and the public  Expand efforts to monitor the prescribing of these drugs, including calling upon every state to set up a program (43 so far)  Make it easier for consumers to dispose of drugs  Shut down “pill mills” and reduce doctor shopping
  • 17. Educating Prescribers  Training: substance abuse in general curriculum  DEA licensure: requiring specific educational content  Manufacturers: requiring “re”-educational funding Opioid Risk Evaluation and Mitigation Strategy (REMS)  Physicians for Responsible Opioid Prescribing (PROP)  Best Practices for Emergency Medicine
  • 18. Washington State  Agency Medical Directors Group  Published guidelines  Opiate dosing calculator (web and app)  Free patient assessment tools  Free 4 hour CME activity  Searchable Directory of Pain Management Specialists  Other resources
  • 19. What do prescribers need to do?  Establish a clear upper limit on dosing  Written care agreements  No early refills or replacement of lost or stolen  Refills only on clinic visits  Random urine screening  Red flags: end access  State monitoring system  Engage family in safety education
  • 20. Conclusion  Historically Opiate Addiction is linked to commercialization  Prescription Opiates have legitimate medical role  A large percentage end up being misused or abused  Unintentional deaths have skyrocketed  Public education is important  Prescribers need greater education  States can help with monitoring, disposal programs, shutting down pill mills, and doctor shopping